Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Talevi

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Chemistry|August 27, 2019
<i>In silico</i> Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2Lucas N Alberca, Sara R Chuguransky, Cora L Álvarez, et al.
Bioorganic & Medicinal Chemistry|April 10, 2007
Application of descriptors based on Lipinski's rules in the QSPR study of aqueous solubilitiesPablo R Duchowicz, Alan Talevi, Carolina Bellera, et al.
Journal of Chemical Information and Modeling|June 10, 2022
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small MoleculesDenis N Prada Gori, Manuel A Llanos, Carolina L Bellera, et al.
Thescientificworldjournal|March 5, 2014
Identification of levothyroxine antichagasic activity through computer-aided drug repurposingCarolina L Bellera, Darío E Balcazar, Lucas Alberca, et al.
Journal of Chemical Information and Modeling|August 3, 2013
Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effectsCarolina L Bellera, Darío E Balcazar, Lucas Alberca, et al.
Molecular Diversity|July 15, 2021
Ensemble learning application to discover new trypanothione synthetase inhibitorsJuan I Alice, Carolina L Bellera, Diego Benítez, et al.
Expert Opinion on Drug Discovery|December 21, 2020
Can drug repurposing strategies be the solution to the COVID-19 crisis?Carolina L Bellera, Manuel Llanos, Melisa E Gantner, et al.
Biomed Research International|August 29, 2013
Development of conformation independent computational models for the early recognition of breast cancer resistance protein substratesMelisa Edith Gantner, Mauricio Emiliano Di Ianni, María Esperanza Ruiz, et al.
Frontiers in Pharmacology|October 6, 2025
Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical modelMonserrat Fuentes-Mejia, Maximiliano J Fallico, Alan Talevi, et al.
Journal of Chemical Information and Modeling|June 13, 2022
Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity <i>In Vivo</i>Manuel A Llanos, Nicolás Enrique, María L Sbaraglini, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Chemistry|August 27, 2019
<i>In silico</i> Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2Lucas N Alberca, Sara R Chuguransky, Cora L Álvarez, et al.
Bioorganic & Medicinal Chemistry|April 10, 2007
Application of descriptors based on Lipinski's rules in the QSPR study of aqueous solubilitiesPablo R Duchowicz, Alan Talevi, Carolina Bellera, et al.
Journal of Chemical Information and Modeling|June 10, 2022
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small MoleculesDenis N Prada Gori, Manuel A Llanos, Carolina L Bellera, et al.
Thescientificworldjournal|March 5, 2014
Identification of levothyroxine antichagasic activity through computer-aided drug repurposingCarolina L Bellera, Darío E Balcazar, Lucas Alberca, et al.
Journal of Chemical Information and Modeling|August 3, 2013
Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effectsCarolina L Bellera, Darío E Balcazar, Lucas Alberca, et al.
Molecular Diversity|July 15, 2021
Ensemble learning application to discover new trypanothione synthetase inhibitorsJuan I Alice, Carolina L Bellera, Diego Benítez, et al.
Expert Opinion on Drug Discovery|December 21, 2020
Can drug repurposing strategies be the solution to the COVID-19 crisis?Carolina L Bellera, Manuel Llanos, Melisa E Gantner, et al.
Biomed Research International|August 29, 2013
Development of conformation independent computational models for the early recognition of breast cancer resistance protein substratesMelisa Edith Gantner, Mauricio Emiliano Di Ianni, María Esperanza Ruiz, et al.
Frontiers in Pharmacology|October 6, 2025
Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical modelMonserrat Fuentes-Mejia, Maximiliano J Fallico, Alan Talevi, et al.
Journal of Chemical Information and Modeling|June 13, 2022
Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity <i>In Vivo</i>Manuel A Llanos, Nicolás Enrique, María L Sbaraglini, et al.
Pageof 9